Jarro-Dophilus Infant Probiotic Drops By Jarrow Formulas Overview & Drug Interactions
Check For Interactions With Jarro-Dophilus Infant Probiotic Drops
Supplement: Jarro-Dophilus Infant Probiotic Drops by Jarrow Formulas
Jarro-Dophilus Infant Probiotic Drops Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Bifidobacterium longum subsp. infantis M-63
| Ingredient Group | Bifidobacterium longum |
|---|---|
| Category | bacteria |
Drugs that interact with Jarro-Dophilus Infant Probiotic Drops by Jarrow Formulas
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Infants |
|---|---|
| Minimum serving Sizes: |
0.5 mL
|
| Maximum serving Sizes: |
0.5 mL
|
| Servings per container | 30 |
| UPC/BARCODE | 790011030140 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Bifidobacterium longum subsp. infantis M-63 |
0 NP
|
Bifidobacterium longum |
--
|
| Other Ingredients: |
Medium Chain Triglycerides
Tapioca Starch
Calcium Phosphate
Vitamin E
Forms
Citric Acid
|
|---|
Label Statments:
| Suggested/Recommended/Usage/Directions |
- Usage: For newborns to infants up to 6 months old, add 10 drops, once daily, to foods, lukewarm milk, or an infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use.
|
|---|---|
| Storage |
- No refrigeration necessary
Does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77 degrees F (25 degrees C).
|
| Brand IP Statement(s) |
- 2020 Jarrow Formulas
- U.S. Patent-Pending
|
| Formula |
- Bifidobacterium Longum Subsp. Infantis M-63
Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function.
B. infantis is the predominant intestinal organism found in breast-fed infants. B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants.
B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.
Jarro-Dophilus Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.
- 1 billion live bacteria guaranteed
With clinically documented B. infantis M-63
|
| General Statements |
- The developing intestinal microflora of newborns is up to 90% B. infantis
- 33+ years probiotic pioneer since 1986
- Strains Matter
When it comes to effective probiotics, clinically documented Strains Matter.
- 01420BABDROP PROD # 103014
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
| FDA Statement of Identity |
- Probiotic Supplement
|
| Formulation |
- No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
- Live Bacteria Guarantee
Jarrow Formulas Probiotics are formulated to ensure the number of live probiotic bacteria are guaranteed by the best used date, and not at "time of manufacture."
- Suitable for vegans/vegetarians.
|
Brand Information
See all products by this brand
| Distributed exclusively by | |
|---|---|
| Name | Jarrow Formulas Superior Nutrition and Formulation |
| City | Los Angeles |
| State | CA |
| ZipCode | 90035-4317 |
| Phone Number | (866) 459-4154 |
| Web Address | www.jarrow.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.